Willow Biosciences (CANSF) Stock Price, News & Analysis

Company Overview

Willow Biosciences Inc. is a Canadian biotechnology company that develops and manufactures specialty cannabinoids through fermentation-based production. Leveraging a proprietary yeast platform, the company engineers strains to produce high‐purity rare cannabinoids such as cannabigerol (CBG), cannabidiol (CBD) and other minor cannabinoids. This approach offers a scalable, consistent and sustainable alternative to traditional plant extraction methods, addressing supply chain challenges and quality variability associated with botanical sources.

The company operates a demonstration‐scale biomanufacturing facility in Calgary, Alberta, where it optimizes fermentation processes, downstream extraction and purification protocols. Willow Biosciences collaborates with contract development and manufacturing organizations (CDMOs) and academic partners to advance process development and analytical capabilities. Its products target pharmaceutical, nutraceutical, cosmetic and research markets, supplying active pharmaceutical ingredient (API)‐grade cannabinoids for drug development, clinical trials and consumer product formulations.

Founded in 2015 by alumni of the University of Calgary’s Synthetic Biology Centre, Willow Biosciences went public on the Canadian Securities Exchange under the ticker “WBIO” and trades in the U.S. over‐the‐counter market as CANSF. The company is led by President and Chief Executive Officer Kam Daya, whose team brings expertise in bioprocess engineering, regulatory affairs and life‐science commercialization. Willow Biosciences continues to expand its product pipeline and scale its manufacturing capacity to meet growing global demand for high‐purity cannabinoid ingredients.

Key Stats

• Today's Range: $0.12 to $0.13
• 50-Day Range: $0.10 to $0.14
• 52-Week Range: $0.01 to $0.39
• Volume: 25,000 shs
• Average Volume: 15,398 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CANSF Stock Analysis - Frequently Asked Questions

How have CANSF shares performed this year?

Willow Biosciences' stock was trading at $0.0405 at the beginning of 2025. Since then, CANSF stock has increased by 210.6% and is now trading at $0.1258.

How do I buy shares of Willow Biosciences?

Shares of CANSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 10/16/2025
• Next Earnings (Estimated): 11/12/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CANSF
• CIK: N/A
• Web: www.willowbio.com
• Phone: (403) 910-5140
• Fax: N/A
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A